CEO Yehiel Tal highlighted advancements in CollPlant's proprietary photocurable dermal filler, emphasizing its potential as a game-changer in the $6.3 billion market for aesthetic medicine.

A video on the app recently went viral where user @Samiasauce talks about her experience using volufiline to fill her hollow ...